Media

Applied Molecular Transport (AMT) is a privately held, clinical-stage biopharmaceutical company that is applying its proprietary bioengineering technology platforms to create transformative oral biological therapies for patients with severe autoimmune, metabolic and inflammatory diseases.  The company is headquartered in South San Francisco, California. 

In the News

Upcoming Events

No events scheduled at this time.